CYFIP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.468400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.457200E-01
Normal-vs-Stage2
5.380600E-01
Normal-vs-Stage3
4.299600E-01
Normal-vs-Stage4
7.322400E-01
Stage1-vs-Stage2
5.226200E-01
Stage1-vs-Stage3
6.584600E-01
Stage1-vs-Stage4
5.197400E-01
Stage2-vs-Stage3
2.844800E-01
Stage2-vs-Stage4
9.252200E-01
Stage3-vs-Stage4
4.056200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.254600E-01
Normal-vs-AfricanAmerican
5.254000E-01
Normal-vs-Asian
5.330000E-01
Caucasian-vs-AfricanAmerican
9.236200E-01
Caucasian-vs-Asian
9.084800E-01
AfricanAmerican-vs-Asian
9.945800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.465200E-01
Normal-vs-Female
5.973000E-01
Male-vs-Female
1.025240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.724400E-01
Normal-vs-Age(41-60Yrs)
7.232400E-01
Normal-vs-Age(61-80Yrs)
3.362000E-01
Normal-vs-Age(81-100Yrs)
6.186000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.887000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.357800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.010400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.450500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.083200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.899200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.475400E-01
Normal-vs-Daily Drinker
4.234800E-01
Normal-vs-Weekly Drinker
6.418800E-01
Normal-vs-Occasional Drinker
5.473800E-01
Normal-vs-Social Drinker
7.159000E-01
Non Drinker-vs-Daily Drinker
7.930400E-01
Non Drinker-vs-Weekly Drinker
6.380000E-01
Non Drinker-vs-Occasional Drinker
6.784600E-01
Non Drinker-vs-Social Drinker
5.139600E-01
Daily Drinker-vs-Weekly Drinker
5.240400E-01
Daily Drinker-vs-Occasional Drinker
5.363600E-01
Daily Drinker-vs-Social Drinker
4.248200E-01
Weekly Drinker-vs-Occasional Drinker
9.155200E-01
Weekly Drinker-vs-Social Drinker
8.777600E-01
Occasional Drinker-vs-Social Drinker
7.791200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.614600E-01
Normal-vs-Grade 2
4.640800E-01
Normal-vs-Grade 3
1.604150E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.362390E-02
Grade 1-vs-Grade 3
1.436400E-04
Grade 1-vs-Grade 4
3.614600E-01
Grade 2-vs-Grade 3
1.060420E-02
Grade 2-vs-Grade 4
4.640800E-01
Grade 3-vs-Grade 4
1.604150E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.024200E-01
Normal-vs-NonDiabetic
4.794200E-01
Diabetic-vs-NonDiabetic
1.891640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.861400E-01
Normal-vs-NoPancreatitis
4.207600E-01
Pancreatitis-vs-NoPancreatitis
1.220360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.193000E-01
Normal-vs-N1
5.617600E-01
N0-vs-N1
1.404410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.001800E-01
Normal-vs-TP53-NonMutant
2.920400E-01
TP53-Mutant-vs-TP53-NonMutant
8.935900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
